CD47 and neoplasm: TSP-1 binding to CD47 activates vascular growth factor (VEGF) and its receptor (VEGFR2) to regulate angiogenesis while CD47 binding to integrin αVβ3 promotes neovascularization that facilitates plaque formation, tumor cell growth, and the spread of inflammation.